Archive for the ‘Conferences’ Category

Medicinal Chemistry Residential School – 17-21 June 2013, Loughborough University, UK

We are delighted to announce that the RSC Medicinal Chemistry Residential School, which has trained some of the world’s leading medicinal chemists in the pharmaceutical industry over the past thirty years, will return this summer.

Highly valued by the community, this intensive course aims to aid the transition from synthetic chemistry to medicinal chemistry and will explore current understanding of the factors governing modern drug discovery.

If you are a graduate or post-doctoral chemist with 1-5 years’ experience in the field of drug research or a final year PhD student in pharmacy and organic chemistry contemplating a career in medicinal chemistry, be sure to secure your place today.

For full details about the RSC Medicinal Chemistry Residential School, please visit the dedicated webpage.

Medicinal Chemistry Residential School – 17-21 June 2013, Loughborough University, UK

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Spinks Symposium on Regenerative Medicine: last chance to register

Spinks Symposium
Regenerative Medicine
28 January 2013
The Chemistry Centre, Burlington House, London
http://rsc.li/spinks-2013

 

Registration deadline – Friday 18th January 2013

This is your last chance to attend the 2013 Spinks Symposium: Regenerative Medicine as registration closes in just one week. Join us for this stimulating event which will:

  • explore the critical issues that underpin developments in regenerative medicine
  • provide a clear understanding of the challenges involved in translating research outputs into application
  • focus on how medicinal chemistry/chemical biology research might provide a springboard to therapeutic development

Who will be there?
The 2013 Spinks symposium will bring together researchers from industry, academia and the wider medical sciences sectors for a range of inspiring presentations, case studies and discussion groups delivered by the following speakers:

  • Dr Alex Alanine, F.Hoffmann-La Roche
  • Dr Lilian Hook, Plasticell
  • Professor Chris Mason, University College London
  • Dr Angela Russell, University of Oxford
  • Dr Dennis Schade, TU Dortmund
  • Dr Paul Whiting, Pfizer Neusentis

 How do I register?
Secure you place using our quick and simple online booking system and don’t forget registration closes on Friday 18th January 2013. For further details on the 2013 Spinks Symposium: Regenerative Medicine, please visit the dedicated webpage.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Meet the MedChemComm Editorial team – see where and when you can meet us in 2013

The MedChemComm Editorial team will be attending a number of conferences in 2013 and we would be delighted to meet you there.  

We’re also the team behind MedChemComm’s sister journals Organic & Biomolecular Chemistry, Natural Product Reports, and the latest addition to the portfolio, Toxicology Research, so we’ll happily discuss your interdisciplinary research work. In fact, many of our authors choose to publish their research across all of these titles.    

Here are just some of the conferences where you can meet us in the coming months:  

RSC India Roadshow, visiting Kolkata, Pune and Bangalore – 5-11 February 2013, India – View the full details, including the confirmed speakers’ list– Meet Richard
Society of Toxicology’s 52nd Annual Meeting –10-14 March 2013, San Antonio, Texas, USA – Meet Marie
40th Lakeland Heterocyclic meeting – 9-13 May 2013, Grasmere, UK – Meet Marie
Frontiers in Medicinal Chemistry (EFMC) – 23-26 June 2013, San Francisco, USA – Meet Richard
8-ISMSC (International Symposium on Macrocyclic and Supramolecular Chemistry) – 07-11 July 2013, Washington DC, USA – Meet Richard
ESOC 2013 (8th European Symposium on Organic Chemistry) – 08-12 July 2013, Marseille, France – Meet Marie
OMCOS 17 (IUPAC Conference on Organometallic Chemistry Towards Organic Synthesis)- 28 July to 01 August 2013, Fort Collins, USA – Meet Marie
EUROTOX 2013– 01-04 September 2013, Interlaken, Switzerland – Meet Marie
Fall ACS meeting– 08-12 September 2013, Indianapolis, USA – Meet Richard
Asian Medicinal Chemistry Conference – October 2013, Taipei, Taiwan – Meet Richard
15th BMOS – Brazilian Meeting on Organic Synthesis, 10-13 November 2013, Campos do Jordão, Brazil – Meet Richard    

Let us know if you are planning on attending any of these meetings, as it would be lovely to see you there!   

     

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Challenges in Chemical Biology (ISACS11) – Call for Abstracts

We are proud to announce that the significant International Symposia on Advancing the Chemical Sciences (ISACS) series will return in 2013 to include Challenges in Chemical Biology (ISACS11) on 23-26 July 2013 in Boston, UK.

Abstracts are now invited for this event so submit today and take advantage of this exceptional opportunity to present your work alongside scientists from across the globe.

For details of speakers and conferences themes, please visit the dedicated website.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Spinks Symposium 2013: Regenerative Medicine

 28 January 2013 

Chemistry Centre, Burlington House, London

The therapeutic promise of regenerative medicine, as a way to restore aging or damaged tissues and organs, is one of the most exciting areas of medicines research. With the proportion of older people increasing, degenerative and chronic diseases are a major challenge. To move forward, the chemical sciences have a vital role to play in understanding

  • disease mechanisms
  • signalling of stem cells
  • cellular differentiation
  • new methodologies for surface modification

The 2013 Spinks Symposium will explore the critical issues that underpin developments in regenerative medicine and provide a clear understanding of the challenges involved in translating research outputs into application. Particular emphasis will be put on how medicinal chemistry/chemical biology research might provide a springboard to therapeutic development. Researchers from industry, academia and the wider health sciences sectors will join together for this stimulating workshop, including oral presentations discussion groups, flash presentations and a comprehensive poster session.

How can I get involved?

  • Abstracts for the poster programme are now invited. Take full advantage of this exceptional opportunity to present your work and submit before Friday 21st December.
  • Registration is also open and if you would like to benefit from the early bird rates be sure to secure your place before Friday 21st December
Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Upcoming event: The Discovery of Abiraterone

6 pm, 20th September 2012
Chemistry Centre, Burlington House, London

The nature of drug discovery is changing, but the UK remains a world leader in the development of new medicines. The discovery of Abiraterone is one recent success, developed at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital (RMH). In 2011, it completed its journey from an idea to a life-extending treatment for men with advanced prostate cancer.

Keynote speaker: Professor Johann de Bono, Institute of Cancer Research  

Professor de Bono led on the drug’s development, taking it from Phase I first-in-man trials to the successful completion of Phase III trials. During his lecture he will highlight the Institute of Cancer Research’s unique partnership with the Royal Marsden hospital, with an emphasis on the bench-to-bedside approach that has already made a real impact on cancer patients’ lives. Professor de Bono’s talk will be followed by a chaired panel discussion which will address the question:

How can discovery programmes such as the successful work that led to the discovery of Abiraterone be repeated within the UK academic environment?

The evening will finish with a wine reception. This event is free to attend, but delegates must pre-register to guarantee admittance. Further details and online registration can be found at www.rsc.org/discovery-of-abiraterone

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Submit a poster for Lipids and Membrane Biophysics: Faraday Discussion 161

There’s still just time to submit a poster for Lipids and Membrane Biophysics: Faraday Discussion 161 – by the deadline date 13 July.

This Faraday Discussion will consider recent developments in the study of biomembrane structure, ordering and dynamics, with particular emphasis on the roles of lipids in these phenomena. Registration is quick and simple via our online booking system, so act today and benefit from early bird savings.

Why choose to come to a Faraday Discussion? They have a unique format – all papers are circulated in advance and all discussion contributions are recorded for publication in the abstract book after the event. You can also have your own poster space at the meeting, so submit yours now before the deadline of 13 July.

Come and discuss new experimental and theoretical findings and novel methodologies, as we focus on exploring the relevance of concepts from amphiphile self-assembly and soft matter physics to understanding biomembranes.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

The Discovery of Brilinta – Daring to be Different

You are invited to attend the Royal Society of Chemistry’s Healthcare Innovation event on Wednesday 18 April, 5.30 pm at The Chemistry Centre, Burlington House, London, W1J 0BE

The Discovery of Brilinta – Daring to be Different
Dr John Dixon CChem FRSC

Over the last 30 years, improvements in healthcare and technology have led to an increase in life expectancy and a general rise in the level of health. The UK has for decades been a world leader in medicines discovery and research. The Discovery of Brilinta is a unique example of UK drug discovery excellence and is a potential blockbuster for the treatment of antithrombotic conditions for use in reducing heart attacks and cardiovascular death.
Our keynote speaker, Dr John Dixon will outline aspects of the discovery of Brilinta (ticagrelor) from the chemical starting point of ATP leading to a complex carbocyclic nucleoside analogue which was developed into a immediate release tablet. Ticagrelor is a reversible, selective P2Y12-receptor antagonist which was finally approved by the FDA in 2011 and is marketed in most countries.

The RSC has organised this event to highlight the pivotal role played by medicinal chemists in the discovery of Brilinta as well as provide a discussion forum for anyone who has an interest in the future of UK drug discovery. The nature of drug discovery is changing and is under considerable pressure due to escalating R&D costs and high drug discovery failure rates. Will it be possible to peruse complex drug discovery programmes in a fragmented environment?
I do hope you are able to join us for what will prove to be a very exciting and interesting lecture and discussion. Refreshments are available from 5.30 pm. The lecture will start at 6.00 pm and will be followed by a wine reception.

Please register here by 13 April or RSVP to sciencepolicy@rsc.org. Spaces are limited and will be allocated on a first come, first served basis.

About the Keynote speaker:
Dr John Dixon has 36 years experience of medicinal chemistry and drug discovery. He was Head of Medicinal Chemistry for 20 years at Fisons, Vice President of Pre Clinical R&D at Astra Charnwood for 4 years and Vice President of Drug Discovery at AstraZeneca Charnwood for 9 years. As VP of AstraZeneca Charnwood he was involved in development of 35 candidate drugs, particularly in the respiratory area. In July 2008, John became Director of JD International Consulting Ltd, an independent consultancy working with pharmaceutical and biotech organisations around the world. John is a Fellow of the Royal Society of Chemistry and Member of the American Chemical Society and has served on several professional and academic advisory committees.

Posted on behalf of the Conferences and Events team

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Meet the MedChemComm team

The MedChemComm team will be attending a number of conferences in 2012 and we would be delighted to meet you.

Dr Marie Cote, Deputy Editor

Dr Richard Kelly, Managing Editor

Here are just some of the conferences where you can meet us in the coming months:

Please let us know if you are planning on attending any of these meetings, as it would be lovely to meet you there!

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Challenges in Organic Chemistry and Chemical Biology symposium

The first of the International Symposia on Advancing the Chemical Sciences (ISACS) series next year is to be Challenges in Organic Chemistry and Chemical Biology (ISACS7) on 12 – 15 June at the University of Edinburgh, UK.

See the excellent list of confirmed speakers and details of the abstract submission process here.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)